CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers. Yi M, Peng C, Xia B, Gan L, et al. Clin Breast Cancer 2022;22:e191-e198.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yi M, Peng C, Xia B, Gan L, et al. CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers. Clin Breast Cancer 2022;22:e191-e198.
PMID: 34284965